Related Experiment Video
Updated: Jul 10, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
Published on: April 10, 2018
Severe COVID-19 multisystem inflammatory syndrome versus severe dengue in children from Indonesia: a cross-sectional
Anggraini Alam1, Fina Meilyana Andriyani2, Stanza Uga Peryoga2
1Infection & Tropical Diseases Division, Department of Child Health, Faculty of Medicine, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung, Indonesia. anggraini.alam@unpad.ac.id.
Insights
Distinguishing severe multisystem inflammatory syndrome in children (MIS-C) from severe dengue is crucial. Key differences in age, symptoms like rash, and lab values such as platelet count, AST, and D-dimer levels aid in diagnosis.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Differentiating severe multisystem inflammatory syndrome in children (MIS-C) from severe dengue presents diagnostic challenges in endemic regions, especially during the COVID-19 pandemic.
- Both conditions share overlapping symptoms like fever, multiorgan involvement, and shock, complicating early identification and management.
- Accurate distinction is vital for appropriate clinical intervention and patient outcomes.
Purpose of the Study:
- To identify key clinical and laboratory differences between severe MIS-C and severe dengue in pediatric patients.
- To provide guidance for clinicians managing febrile illnesses with potential overlap between MIS-C and severe dengue.
- To improve diagnostic accuracy in resource-limited settings during concurrent epidemics.
Main Methods:
- A retrospective analysis of medical records for children under 18 hospitalized with severe MIS-C or severe dengue.
- Inclusion criteria focused on patients admitted to the Pediatric Intensive Care Unit (PICU) between December 2020 and July 2022.
- Comparative and descriptive statistical analyses were employed to assess differences between the two patient groups.
Main Results:
- The study included 17 severe dengue patients and 4 severe MIS-C patients.
- Severe MIS-C patients were older (average 11.5 years) than severe dengue patients (average 6.2 years) (p=0.034).
- Significant differences were observed in the presence of rash (p=0.049), nonpurulent conjunctivitis (p=0.035), platelet counts (p=0.006), AST levels (p=0.026), D-dimer levels (p=0.025), and cardiac abnormalities (100% in MIS-C vs. 5.9% in dengue).
Conclusions:
- Age, specific symptoms (rash, nonpurulent conjunctivitis), and laboratory markers (platelet count, AST, D-dimer) are valuable in differentiating severe MIS-C from severe dengue.
- Cardiac involvement is a prominent feature in severe MIS-C, distinguishing it from severe dengue.
- These findings can aid clinicians in the differential diagnosis of these critical pediatric conditions.
Introduction:
Severe multisystem inflammatory syndrome in children (MIS-C) and severe dengue are challenging to identify during the COVID-19 pandemic in dengue-endemic areas. Fever, multiorgan involvement, and shock characterize both severe MIS-C and severe dengue. Distinguishing between the two diseases is beneficial in initiating proper management.
Methods:
Medical records of children < 18 years old who were hospitalized at Hasan Sadikin General Hospital's PICU between December 2020 and July 2022 with severe MIS-C or severe dengue were recorded. Differences were assessed using comparative and descriptive analyses.
Results:
Seventeen severe dengue patients and 4 severe MIS-C were included. The average age of severe MIS-C was 11.5 years (SD ± 2.9, 95% CI), and that of severe dengue patients was 6.2 years (SD ± 4.4, 95% CI) (p value = 0.034, 95%). Fever and abdominal pain were the most common symptoms in both groups (p = 0.471, 95% CI). Rash (p = 0.049) and nonpurulent conjunctivitis (p = 0.035) were two symptoms with significant differences. The highest platelet count (p-value = 0.006, 95% CI), AST (p-value = 0.026, 95% CI), and D-dimer level (p-value = 0.025, 95% CI) were significantly different between the two cohorts. Cardiac abnormalities were found in all (100%) severe MIS-C patients, but only one (5.9%) in severe dengue patients.
Conclusion:
Age, rash, nonpurulent conjunctivitis, platelet count, AST and D-dimer level may distinguish severe MIS-C from severe dengue fever.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Respiratory Syncytial Virus Disease
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction

